UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy

Annals of oncology, 2010-05, Vol.21 (5), p.1046-1052

2010

Volltextzugriff (PDF)

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report

Annals of oncology, 2007-11, Vol.18 (11), p.1851-1855

2007

Volltextzugriff (PDF)

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report

Neurology, 2008-10, Vol.71 (17), p.1355-1360

2008

Volltextzugriff (PDF)

Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment

Annals of hematology, 2015-11, Vol.94 (11), p.1839-1843

2015

Volltextzugriff (PDF)

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

British journal of cancer, 2014-09, Vol.111 (6), p.1241-1248

2014

Volltextzugriff (PDF)

A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency

Annals of oncology, 2007-01, Vol.18 (1), p.129-135

2007

Volltextzugriff (PDF)

After breast cancer: A nurse practitioner led model of care for women on adjuvant endocrine treatment

Annals of oncology, 2019-05, Vol.30, p.iii67-iii67

2019

Volltextzugriff (PDF)

Do we need another selective estrogen receptor modulator for the adjuvant treatment of breast cancer?

Current oncology (Toronto), 2013-08, Vol.20 (4), p.191-192

Shenkier, T

2013

Volltextzugriff (PDF)

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer

European journal of cancer (1990), 2013-07, Vol.49 (11), p.2469-2475

2013

Volltextzugriff (PDF)

Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer

Canadian Medical Association journal, 2004-03, Vol.170 (6), p.983-994

2004

Volltextzugriff (PDF)

Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency

Journal of clinical oncology, 2002-01, Vol.20 (1), p.197-204

Shenkier, T. N.

2002

Volltextzugriff (PDF)

Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5034-5043

2005

Volltextzugriff (PDF)

Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: A cross-sectional analysis

Annals of oncology, 1999-08, Vol.10 (8), p.961-964

1999

Volltextzugriff (PDF)

Improved Outcome of Human Immunodeficiency Virus-Associated Plasmablastic Lymphoma of the Oral Cavity in the Era of Highly Active Antiretroviral Therapy: A Report of Two Cases

Leukemia & lymphoma, 2004-09, Vol.45 (9), p.1881-1885

2004

Volltextzugriff (PDF)

Abstract P2-10-07: A prospective clinical utility study of the impact of the 21-gene recurrence score (RS) assay in the treatment of estrogen receptor positive (ER+), HER2 negative (HER2-), 1-3 node positive (N+) breast cancer (BC)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-10-07

2018

Volltextzugriff (PDF)

207PAfter breast cancer: A nurse practitioner led model of care for women on adjuvant endocrine treatment

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

Paclitaxel and radiation-recall dermatitis

Journal of clinical oncology, 1994-02, Vol.12 (2), p.439-439

1994

Volltextzugriff (PDF)

Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1941-1950

2005

Volltextzugriff (PDF)

Hepatitis C and B-cell non-Hodgkin's lymphoma: a geographically variable association?

The American journal of medicine, 2000-03, Vol.108 (4), p.350-351

2000

Volltextzugriff (PDF)

A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer

Annals of oncology, 1998-11, Vol.9 (11), p.1247-1249

1998

Volltextzugriff (PDF)

Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: Natural history of relapse after initial complete response and prognostic variables defining outcome after relapse

Annals of oncology, 1997-11, Vol.8 (11), p.1125-1132

1997

Volltextzugriff (PDF)

Primary CNS Lymphoma of T-Cell Origin: A Descriptive Analysis From the International Primary CNS Lymphoma Collaborative Group

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2233-2239

2005

Volltextzugriff (PDF)

The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8034-8034

2011

Volltextzugriff (PDF)

A phase II trial of a neoadjuvant platinum-containing regimen for locally advanced breast cancer: Pathologic response, long-term follow-up, and correlation with biomarkers

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e11510-e11510

2009

Volltextzugriff (PDF)

Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel and capecitabine for HER2-negative locally advanced breast cancer (LABC): A multicenter study from British Columbia

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.598-598

2009

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(132)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(58)
Science & Technology
(58)
Humans
(50)
Female
(42)
Middle Aged
(39)
Oncology
(38)
Adult
(36)
Aged
(33)
Male
(28)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Aged, 80 And Over
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Hematology
(18)
Prognosis
(16)
Adolescent
(15)
Treatment Outcome
(14)
Hematologic And Hematopoietic Diseases
(13)
Retrospective Studies
(13)
Tumors
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report

Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency

After breast cancer: A nurse practitioner led model of care for women on adjuvant endocrine treatment

Do we need another selective estrogen receptor modulator for the adjuvant treatment of breast cancer?

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer

Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer

Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency

Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: A cross-sectional analysis

Improved Outcome of Human Immunodeficiency Virus-Associated Plasmablastic Lymphoma of the Oral Cavity in the Era of Highly Active Antiretroviral Therapy: A Report of Two Cases

Abstract P2-10-07: A prospective clinical utility study of the impact of the 21-gene recurrence score (RS) assay in the treatment of estrogen receptor positive (ER+), HER2 negative (HER2-), 1-3 node positive (N+) breast cancer (BC)

207PAfter breast cancer: A nurse practitioner led model of care for women on adjuvant endocrine treatment

Paclitaxel and radiation-recall dermatitis

Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis

Hepatitis C and B-cell non-Hodgkin's lymphoma: a geographically variable association?

A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer

Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: Natural history of relapse after initial complete response and prognostic variables defining outcome after relapse

Primary CNS Lymphoma of T-Cell Origin: A Descriptive Analysis From the International Primary CNS Lymphoma Collaborative Group

The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy

A phase II trial of a neoadjuvant platinum-containing regimen for locally advanced breast cancer: Pathologic response, long-term follow-up, and correlation with biomarkers

Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel and capecitabine for HER2-negative locally advanced breast cancer (LABC): A multicenter study from British Columbia

Suchergebnisse filtern